Diversified Trust’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $723K | Buy |
12,248
+138
| +1% | +$8.15K | 0.02% | 475 |
|
|
2025
Q1 | $887K | Sell |
12,110
-701
| -5% | -$51.3K | 0.02% | 406 |
|
|
2024
Q4 | $1.06M | Sell |
12,811
-5,935
| -32% | -$491K | 0.03% | 355 |
|
|
2024
Q3 | $1.34M | Sell |
18,746
-4,070
| -18% | -$291K | 0.03% | 299 |
|
|
2024
Q2 | $1.56M | Buy |
22,816
+1,450
| +7% | +$99.3K | 0.04% | 243 |
|
|
2024
Q1 | $1.15M | Buy |
21,366
+7,675
| +56% | +$412K | 0.03% | 288 |
|
|
2023
Q4 | $730K | Buy |
13,691
+1,650
| +14% | +$87.9K | 0.02% | 382 |
|
|
2023
Q3 | $598K | Buy |
12,041
+1,374
| +13% | +$68.2K | 0.02% | 395 |
|
|
2023
Q2 | $635K | Buy |
10,667
+675
| +7% | +$40.2K | 0.02% | 390 |
|
|
2023
Q1 | $566K | Sell |
9,992
-1,775
| -15% | -$101K | 0.02% | 423 |
|
|
2022
Q4 | $874K | Sell |
11,767
-645
| -5% | -$47.9K | 0.04% | 270 |
|
|
2022
Q3 | $739K | Buy |
12,412
+1,934
| +18% | +$115K | 0.03% | 277 |
|
|
2022
Q2 | $588K | Buy |
10,478
+666
| +7% | +$37.4K | 0.02% | 340 |
|
|
2022
Q1 | $724K | Buy |
9,812
+785
| +9% | +$57.9K | 0.03% | 336 |
|
|
2021
Q4 | $652K | Buy |
9,027
+650
| +8% | +$46.9K | 0.02% | 363 |
|
|
2021
Q3 | $642K | Buy |
8,377
+1,325
| +19% | +$102K | 0.02% | 324 |
|
|
2021
Q2 | $547K | Sell |
7,052
-25
| -0.4% | -$1.94K | 0.02% | 374 |
|
|
2021
Q1 | $436K | Buy |
7,077
+2,000
| +39% | +$123K | 0.02% | 417 |
|
|
2020
Q4 | $331K | Hold |
5,077
| – | – | 0.01% | 475 |
|
|
2020
Q3 | $251K | Sell |
5,077
-725
| -12% | -$35.8K | 0.01% | 498 |
|
|
2020
Q2 | $277K | Buy |
+5,802
| New | +$277K | 0.01% | 420 |
|
|
2015
Q3 | – | Sell |
-8,000
| Closed | -$205K | – | 436 |
|
|
2015
Q2 | $205K | Sell |
8,000
-3,600
| -31% | -$92.3K | 0.02% | 450 |
|
|
2015
Q1 | $293K | Sell |
11,600
-1,500
| -11% | -$37.9K | 0.03% | 410 |
|
|
2014
Q4 | $311K | Buy |
+13,100
| New | +$311K | 0.03% | 408 |
|
|
2014
Q2 | $341K | Buy |
+14,250
| New | +$341K | 0.03% | 443 |
|
|
2013
Q4 | $318K | Buy |
+15,775
| New | +$318K | 0.03% | 393 |
|